Ticker Details
Arcellx, Inc. Common Stock
IPO Date:	February 4, 2022
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$6.73B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.15 | 2.58%
Avg Daily Range (30 D):	$0.05 | 0.04%
Avg Daily Range (90 D):	$0.64 | 0.93%

Institutional Daily Volume
Avg Daily Volume:	.54M
Avg Daily Volume (30 D):	.8M
Avg Daily Volume (90 D):	1.59M

Trade Size
Avg Trade Size (Sh.):	61
Avg Trade Size (Sh.) (30 D):	113
Avg Trade Size (Sh.) (90 D):	104

Institutional Trades
Total Institutional Trades:	2,886
Avg Institutional Trade:	$4.19M
Avg Institutional Trade (30 D):	$18.11M
Avg Institutional Trade (90 D):	$9.82M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	3

Market Closing Trades
Avg Closing Trade:	$6.14M
Avg Closing Trade (30 D):	$49.35M
Avg Closing Trade (90 D):	$24.15M
Avg Closing Volume:	94.87K

News

Apr 7, 2026 @ 4:06 PM Gilead Acquisition Spree Continues With $3 Billion... Source: Vandana Singh

Mar 24, 2026 @ 5:58 PM Gilead Powers Up Its Inflammation Pipeline With Ov... Source: Vandana Singh

Mar 16, 2026 @ 11:13 PM This $64 Million Biotech Exit Seemingly Missed a 7... Source: Jonathan Ponciano

Mar 4, 2026 @ 7:46 PM Halper Sadeh LLC is Investigating Whether ACLX, VR... Source: Halper Sadeh Llc

Feb 25, 2026 @ 3:09 PM Gilead Snaps Up Arcellx For $115 Per Share â€â€... Source: Vandana Singh

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-4.07	$-1.01	$-4.07
Diluted EPS	$-4.07	$-1.01	$-4.07
Revenue	$22.29M	$1.65M	$22.29M
Gross Profit
Net Income / Loss	$-228.93M	$-58.11M	$-228.93M
Operating Income / Loss	$-253.08M	$-63.68M	$-253.08M
Cost of Revenue
Net Cash Flow	$-25.43M	$1.26M	$-25.43M
PE Ratio